Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.
OBJECTIVE
To investigate whether lentiviral vector (LV)-mediated expression of a dominant negative mutant Rho-kinase (DNROCK) could inhibit activation of the Rho/ROCK signaling pathway and promote neurite outgrowth in a hostile microenvironment mimicking the injured central nervous system (CNS) in vitro.


METHODS
Lentiviral stock was produced using the three-plasmid system by transfecting HEK293 cells. Myelin prepared from rat brain was purified by two rounds of discontinuous density gradient centrifugation and osmotic disintegration. Differentiated PC12 cells and dissociated adult rat dorsal root ganglion (DRG) neurons were transduced with either LV/DNROCK or LV/green fluorescent protein (GFP) and seeded on solubilized myelin proteins. The effect of DNROCK on growth cone morphology was tested by rhodamine-conjugated phalloidin staining. Expression of DNROCK was determined by immunoblotting. The length of the longest neurite, the percentage of neurite-bearing neurons, or the total process outgrowth for all transduced neurons were measured by using the Scion image analysis program.


RESULTS
Transduction of DNROCK inhibited serum-induced stress fiber formation in NIH 3T3 cells and induced enlargement of cell bodies and decreased the phosphorylation levels of MYPT1 in HeLa cells. LV/DNROCK blocked myelin-induced increase in ROCK translocation from cytosol to membrane in LV/GFP-treated PC12 cells. DNROCK promotes neurite outgrowth of differentiated PC12 cells and DRG neurons on myelin protein. LV/DNROCK-transduced PC12 cells had longer neurites than LV/GFP-transduced cells (39.18+/-2.19 microm vs 29.32+/-1.7 microm, P<0.01) on myelin-coated coverslips. Furthermore, a significantly higher percentage of LV/DNROCK-transduced cells had extended neurites than LV/GFP-transduced cells (63.75%+/-8.03% vs 16.3%+/-3.70%, P<0.01). LV/DNROCK-transduced DRG neurons had longer neurite length (325.22+/-10.8 microm vs 202.47+/-9.3 microm, P<0.01) and more primary neurites per cell than those in LV/GFP-transduced cells plated on myelin and laminin (7.8+/-1.25 vs 4.84+/-1.45, P<0.01) or on laminin alone (5.2+/-1.88). LV/DNROCK-transduced cells had significantly larger growth cones (33.12+/-1.06 microm(2)) than LV/GFP-pretreated cells (23.72+/-1.22 microm(2)).


CONCLUSIONS
These results indicate that blocking the RhoA/ROCK signaling pathway by expression of DNROCK is effective in facilitating neurite outgrowth in a microenvironment mimicking injury of central nervous system.
Yang
Ping
P
Department of Neurobiology, Third Military Medical University, Chongqing 400038, China. cp_yang_1999@yahoo.com
Wen
Hui-zhong
HZ
Zhang
Jin-hai
JH
D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D002490:Central Nervous System / Q000293:injuries*; D003599:Cytoskeleton / Q000378:metabolism; D005727:Ganglia, Spinal / Q000166:cytology; D006801:Humans; D016086:Lentivirus / Q000235:genetics; D051379:Mice; D009154:Mutation; D009186:Myelin Sheath / Q000378:metabolism; D009416:Nerve Regeneration; D016501:Neurites / Q000378:metabolism*; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D021381:Protein Transport; D051381:Rats; D015398:Signal Transduction; D014161:Transduction, Genetic; D054460:rho-Associated Kinases / Q000235:genetics / Q000378:metabolism*
D054460:rho-Associated Kinases
Curr Opin Neurobiol. 1998 Feb;8(1):106-16
9568398
Neuron. 2009 Oct 29;64(2):165-72
19874785
Nat Rev Neurosci. 2000 Dec;1(3):173-80
11257905
Prog Brain Res. 2002;137:371-80
12440379
J Neurosci. 2005 Feb 2;25(5):1113-21
15689547
Nat Med. 2004 Jun;10(6):610-6
15156204
J Biol Chem. 1999 Nov 5;274(45):32418-24
10542285
J Neurobiol. 2000 Aug;44(2):97-113
10934315
Prog Neurobiol. 2006 Feb;78(2):91-116
16487649
Curr Opin Neurobiol. 2004 Feb;14(1):118-24
15018947
Mol Ther. 2009 Dec;17(12):2020-30
19623163
Mol Cell Neurosci. 2005 Mar;28(3):509-23
15737741
Neuron. 2000 May;26(2):431-41
10839361
J Neurochem. 2007 Oct;103(1):181-9
17608642
Semin Perinatol. 2004 Dec;28(6):371-8
15693393
J Neurosci. 1999 Sep 1;19(17):7537-47
10460260
EMBO J. 1994 Jun 1;13(11):2600-10
7516876
J Cell Biol. 1999 Nov 29;147(5):1023-38
10579722
J Cell Biol. 1993 Jun;121(6):1369-83
8509456
J Virol. 1998 Nov;72(11):8463-71
9765382
Nature. 2002 Dec 12;420(6916):629-35
12478284
Genes Cells. 1998 Mar;3(3):177-88
9619630
J Neurotrauma. 2006 Mar-Apr;23(3-4):371-83
16629623
Nat Rev Neurosci. 2003 Sep;4(9):703-13
12951563
J Neurotrauma. 2006 Mar-Apr;23(3-4):309-17
16629618
Biochem Soc Trans. 1995 Aug;23(3):456-9
8566347
Neuron. 2004 Nov 18;44(4):609-21
15541310
J Neurosci. 2004 Oct 6;24(40):8726-40
15470139
J Neurochem. 2006 Mar;96(6):1616-25
16441511
Neuron. 1994 Sep;13(3):757-67
7522484
Exp Cell Res. 2000 Nov 25;261(1):44-51
11082274
Int J Biochem Cell Biol. 2002 Jul;34(7):731-45
11950591
J Neurosci. 2002 Aug 1;22(15):6570-7
12151536
J Neurochem. 1973 Oct;21(4):749-57
4271082
J Neurosci. 2003 Feb 15;23(4):1416-23
12598630